Artículos -

Navegar

Últimos Documentos Autor FCEN - Año Autor FCEN - Revista Año - Revista Revista - Año SubjectPcEn Colores Type

Colección

Lista de

$
0
1
-
1
1
-
1
-
1
-
1
1
1
2
3
4
5
6
7
8
9
a
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
‐
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
a
-
a
-
a
b
-
b
-
b
-
b
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
+
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
c
-
c
-
c
d
-
d
-
d
-
d
-
d
-
d
-
d
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
f
-
f
-
f
f
g
-
g
-
g
-
g
-
g
-
g
-
g
-
g
-
‐
g
-
g
-
‐
g
-
g
h
‐
h
h
-
h
-
h
-
h
-
h
i
-
i
j
k
-
k
-
k
-
k
-
k
-
k
l
-
l
-
l
-
l
-
l
-
l
-
l
l
+
l
±
l
l
m
-
m
-
m
-
m
-
m
-
m
+
m
-
m
-
m
-
m
-
‐
m
n
-
n
-
n
-
n
-
n
o
p
-
p
p
-
p
-
p
q
r
-
r
-
r
s
-
s
-
s
{
s
-
s
t
-
t
‐
-
t
-
t
-
t
t
-
t
u
v
v
w
x
-
x
y
z
α
β
—
,
δ
π
-

Breast Neoplasms

"Chronic expression of wild-type Ret receptor in the mammary gland induces luminal tumors that are sensitive to Ret inhibition" (2018) Gattelli, A.;García Solá, M.E.;Roloff, T.C. (...)Hynes, N.E. Oncogene. 37(29):4046-4054

"Distinct ErbB2 receptor populations differentially interact with beta1 integrin in breast cancer cell models" (2017) Toscani, A.M.;Sampayo, R.G.;Barabas, F.M. (...)Leskow, F.C. PLoS ONE. 12(3)

"Phytochemical Study of the Genus Salpichroa (Solanaceae), Chemotaxonomic Considerations, and Biological Evaluation in Prostate and Breast Cancer Cells" (2017) Basso, A.V.;Leiva González, S.;Barboza, G.E. (...)Nicotra, V.E. Chemistry and Biodiversity. 14(8)

"Predictive outcomes for HER2-enriched cancer using growth and metastasis signatures driven by SPARC" (2017) Guttlein, L.N.;Benedetti, L.G.;Fresno, C. (...)Podhajcer, O.L. Molecular Cancer Research. 15(3):304-316

"RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes" (2016) Recouvreux, M.S.;Grasso, E.N.;Echeverria, P.C. (...)Rubinstein, N. Oncotarget. 7(6):6552-6565

"Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells" (2016) Castillo, L.F.;Tascón, R.;Huvelle, M.A.L. (...)Peters, M.G. Oncotarget. 7(37):60133-60154

"CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs" (2016) De Luca, P.;Dalton, G.N.;Scalise, G.D. (...)De Siervi, A. Oncotarget. 7(14):18798-18811

"The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy" (2014) Orqueda, A.J.;Dansey, M.V.;Español, A. (...)Pecci, A. Biochemical Pharmacology. 89(4):526-535

"Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines" (2014) Cardama, G.A.;Comin, M.J.;Hornos, L. (...)Menna, P.L. Anti-Cancer Agents in Medicinal Chemistry. 14(6):840-851

"Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases" (2014) Martinez, L.M.;Vallone, V.B.F.;Labovsky, V. (...)Chasseing, N.A. Clinical and Experimental Metastasis. 31(2):213-232

"Human adipose tissue from normal and tumoral breast regulates the behavior of mammary epithelial cells" (2013) Pistone Creydt, V.;Fletcher, S.J.;Giudice, J. (...)Calvo, J.C. Clinical and Translational Oncology. 15(2):124-131

"Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions" (2013) Spallanzani, R.G.;Dalotto-Moreno, T.;Raffo Iraolagoitia, X.L. (...)Zwirner, N.W. Cancer Immunology, Immunotherapy. 62(12):1781-1795

"Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis" (2013) Fernández Vallone, V.B.;Hofer, E.L.;Choi, H. (...)Chasseing, N.A. Clinical and Experimental Metastasis. 30(3):317-332

"Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease" (2013) Dalotto-Moreno, T.;Croci, D.O.;Cerliani, J.P. (...)Salatino, M. Cancer Research. 73(3):1107-1117

"Anti-tumor effect of SLPI on mammary but not colon tumor growth" (2013) Amiano, N.O.;Costa, M.J.;Reiteri, R.M. (...)Chuluyan, H.E. Journal of Cellular Physiology. 228(2):469-475

"Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy" (2013) Díaz Flaqué, M.C.;Galigniana, N.M.;Béguelin, W. (...)Elizalde, P.V. Breast Cancer Research. 15(6)

"GTSE1 Is a Microtubule Plus-End Tracking Protein That Regulates EB1-Dependent Cell Migration" (2012) Scolz, M.;Widlund, P.O.;Piazza, S. (...)Bird, A.W. PLoS ONE. 7(12)

"The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins " (2012) Lanari, C.;Giulianelli, S.;Vaqué, J.P. (...)Gutkind, J.S. Medicina (Argentina). 72(4):315-320

"Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer" (2012) Schillaci, R.;Guzmán, P.;Cayrol, F. (...)Elizalde, P.V. BMC Cancer. 12

"Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein" (2012) Goddio, M.V.;Gattelli, A.;Slomiansky, V. (...)Kordon, E.C. Breast Cancer Research and Treatment. 135(3):749-758

"p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior" (2011) Rosenthal, D.T.;Iyer, H.;Escudero, S. (...)Merajver, S.D. Cancer Research. 71(20):6338-6349

"Role of histamine H4 receptor in breast cancer cell proliferation" (2011) Medina, V.A.;Brenzoni, P.G.;Lamas, D.J.M. (...)Rivera, E.S. Frontiers in Bioscience - Elite. 3 E(3):1042-1060

"Mesenchymal stromal cells, colony-forming unit fibroblasts, from bone marrow of untreated advanced breast and lung cancer patients suppress fibroblast colony formation from healthy marrow" (2010) Hofer, E.L.;Labovsky, V.;La Russa, V. (...)Chasseing, N.A. Stem Cells and Development. 19(3):359-369

"Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis" (2008) Giulianelli, S.;Cerliani, J.P.;Lamb, C.A. (...)Lanari, C. International Journal of Cancer. 123(11):2518-2531

"Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways" (2007) Carnevale, R.P.;Proietti, C.J.;Salatino, M. (...)Elizalde, P.V. Molecular Endocrinology. 21(6):1335-1358

"Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients" (2005) Hofer, E.L.;La Russa, V.;Honegger, A.E. (...)Chasseing, N.A. Stem Cells and Development. 14(5):587-594

"Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells" (2005) Proietti, C.;Salatino, M.;Rosemblit, C. (...)Elizalde, P.V. Molecular and Cellular Biology. 25(12):4826-4840

"Cross-talk between signaling pathways regulates alternative splicing: A novel role for JNK" (2005) Pelisch, F.; Blaustein, M.; Kornblihtt, A.R.; Srebrow, A. Journal of Biological Chemistry. 280(27):25461-25469

"Inhibition of serum-stimulated mitogen activated protein kinase by 1α,25(OH)2-vitamin D3 in MCF-7 breast cancer cells" (2004) Capiati, D.A.;Rossi, A.M.;Picotto, G. (...)Boland, R.L. Journal of Cellular Biochemistry. 93(2):384-397

"Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells" (2003) Labriola, L.;Salatino, M.;Proietti, C.J. (...)Elizalde, P.V. Molecular and Cellular Biology. 23(3):1095-1111

"Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E2, and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast cancer patients" (2002) Honegger, A.E.;Hofer, E.L.;Barañao, R.I. (...)Chasseing, N.A. Annals of Hematology. 81(2):80-85

"A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma" (1999) Blajman, C.;Balbiani, L.;Block, J. (...)Delgado, F.M. Cancer. 85(5):1091-1097

"α2-adrenergic effect on human breast cancer MCF-7 cells" (1999) Vázquez, S.M.; Pignataro, O.; Luthy, I.A. Breast Cancer Research and Treatment. 55(1):41-49

"Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15" (1998) Ballaré, C.;Portela, P.;Schiaffi, J. (...)Mordoh, J. Breast Cancer Research and Treatment. 47(2):163-170

"The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo." (1998) Bover, L.;Barrio, M.;Bravo, A.I. (...)Mordoh, J. Cellular and molecular biology (Noisy-le-Grand, France). 44(3):493-504

"Bone marrow fibroblastic progenitors in patients with advanced breast cancer" (1997) Chasseing, N.A.;Trejo, Y.G.;Bordenave, R.H. (...)Rumi, L.S. Breast Cancer Research and Treatment. 45(3):211-218

"Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells" (1995) Ballaré, C.; Barrio, M.; Portela, P.; Mordoh, J. Cancer Immunology Immunotherapy. 41(1):15-22

"Chemiluminescence production by neutrophils and immune complex levels in cancer patients" (1993) Chasseing, N.A.;Barañao, R.I.;Fernández, O. (...)Rumi, L.S. Cancer Investigation. 11(5):517-522

"The increase in cytosolic levels of protein kinase C precedes the growth factor requirements during the transition stem cells to differentiated progeny in the MCF-7 breast tumor cells." (1993) Gomez, M.L.; Resnicoff, M.; Medrano, E.E.; Tellez-Inon, M.T. Cell Biology International. 17(5):495-502

"The expression of progesterone receptors coincides with an arrest of DNA synthesis in human breast cancer" (1991) Ballare, C.;Bravo, A.I.;Sorin, I. (...)Mordoh, J. Cancer. 67(5):1352-1358

"Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor" (1991) Bover, L.;Barrio, M.;Slavutsky, I. (...)Mordoh, J. Breast Cancer Research and Treatment. 19(1):47-56

"Increased secretory activity and estradiol receptor expression are among other relevant aspects of MCF-7 human breast tumor cell growth which are expressed only in the absence of serum" (1990) Medrano, E.E.;Resnicoff, M.;Cafferata, E.G.A. (...)Molinari, B. Experimental Cell Research. 188(1):2-9

"Heme biosynthesis in human breast cancer-mimetic "in vitro" studies and some heme enzymic activity levels" (1990) Navone, N.M.;Polo, C.F.;Frisardi, A.L. (...)del C. Baille, a.M. International Journal of Biochemistry. 22(12):1407-1411

"Growth factors and hormones which affect survival, growth, and differentiation of the MCF-7 stem cells and their descendants" (1989) Resnicoff, M.; Medrano, E.E. Experimental Cell Research. 181(1):116-125

"Effect of estradiol and tamoxifen on the anchorage-independent growth of the subpopulations derived from MCF-7 breast carcinoma cells: Cytogenetic analysis of the stem cell subpopulation" (1988) Podhajcer, O.L.;Resnicoff, M.;Bover, L. (...)Mordoh, J. Experimental Cell Research. 179(1):58-64

"Protein kinase C is differentially regulated by thrombin, insulin, and epidermal growth factor in human mammary tumor cells" (1988) Gomez, M.L.; Medrano, E.E.; Cafferatta, E.G.A.; Tellez-Inon, M.T. Experimental Cell Research. 175(1):74-80

"Role of thrombin in the proliferative response of T-47D mammary tumor cells. Mitogenic action and pleiotropic modifications induced together with epidermal growth factor and insulin" (1987) Medrano, E.E.; Cafferata, E.G.A.; Larcher, F. Experimental Cell Research. 172(2):354-364

"13-cis-Retinal stimulates proliferation and induces intranuclear protein accumulation in the human mammary tumor cells MCF-7" (1987) Resnicoff, M.; Medrano, E.E. Biochemical and Biophysical Research Communications. 143(1):309-315

"Mitoxantrone affects topoisomerase activities in human breast cancer cells" (1986) Crespi, M.D.; Ivanier, S.E.; Genovese, J.; Baldi, A. Biochemical and Biophysical Research Communications. 136(2):521-528

"Dolichol-sugar derivative synthesis in human breast cancer cell line (T47D). Effects of estrogens and antiestrogens" (1985) Santa Cruz, A.R.; Medrano, E.E.; Baldi, A. Biochemical and Biophysical Research Communications. 126(1):382-388

"Transfer of oligosaccharide from oligosaccharide pyrophosphoryl dolichol to endogenous acceptor proteins in human breast malignant and normal tissues" (1985) Santa Cruz, A.R.; Baldi, A. Experientia. 41(7):928-929

"Lipid-bound sugars in malignant human breast tumors - Partial characterization of mannosyl and glucosyl transferase activities" (1983) Santa Cruza, A.R.; Quesada Allue, L.A.; Baldi, A. Molecular and Cellular Biochemistry. 56(1):55-66

"Transcriptional features of fractionated human breast tumor chromatin" (1979) Thierbach, L.I.A.; Rosemblit, N.; Pahn, C.R.; Baldi, A. Acta Physiologica Latino-Americana. 29(1):81-85

"Binding of estradiol receptor complexes to isolated human breast chromatin" (1977) Charreau, E.H.; Baldi, A. Molecular and Cellular Biochemistry. 16(2-3):79-86